Turning vaccine allergy CDSS into a global trust pipeline: Equity, auditability, and workflow safety

Nemorin et al have provided qualitative evidence that specialists view clinical decision support systems (CDSSs) as potentially useful tools for addressing secondary vaccine hesitancy, particularly when there are concerns related to allergic reactions.1 Their work highlights the importance of design features such as rapid interpretability, transparent explanations for patients, and minimal workflow disruption. It also underscores potential pitfalls, including incomplete data capture, unclear accountability, and inconsistent implementation across institutions.